<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Alagille syndrome is an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> condition with <z:hpo ids='HP_0003829'>incomplete penetrance</z:hpo> that is associated mostly with hepatic, cardiac, and <z:hpo ids='HP_0000924'>skeletal abnormalities</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In addition, the association of Alagille syndrome with ocular abnormalities is well known and is considered one of the characteristic features of this condition </plain></SENT>
<SENT sid="2" pm="."><plain>Most commonly, <z:hpo ids='HP_0000627'>posterior embryotoxon</z:hpo>, <z:hpo ids='HP_0000501'>glaucoma</z:hpo>, or <z:hpo ids='HP_0000488'>retinopathy</z:hpo> has been identified in these children </plain></SENT>
<SENT sid="3" pm="."><plain>The authors present 2 patients with Alagille syndrome who, before the age of 3 years old, developed idiopathic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> with documented <z:hpo ids='HP_0002516'>increased intracranial pressure</z:hpo> by lumbar puncture and <z:hpo ids='HP_0001085'>papilledema</z:hpo>, which was responsive to <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> </plain></SENT>
</text></document>